Integer (ITGR) Upgraded at ValuEngine

ValuEngine upgraded shares of Integer (NYSE:ITGR) from a hold rating to a buy rating in a report released on Friday morning.

A number of other research analysts have also recently issued reports on ITGR. Zacks Investment Research cut shares of Integer from a buy rating to a hold rating in a report on Tuesday, January 23rd. Royal Bank of Canada reiterated a neutral rating on shares of Integer in a report on Friday, October 27th. BidaskClub cut shares of Integer from a strong-buy rating to a buy rating in a report on Saturday, October 28th. TheStreet upgraded shares of Integer from a c+ rating to a b- rating in a report on Wednesday, October 18th. Finally, Northcoast Research cut shares of Integer from a buy rating to a neutral rating in a report on Monday, October 23rd. They noted that the move was a valuation call. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Integer has an average rating of Hold and a consensus target price of $51.00.

Integer (NYSE ITGR) opened at $50.10 on Friday. The stock has a market cap of $1,586.66, a PE ratio of 79.53, a PEG ratio of 1.05 and a beta of 1.05. Integer has a twelve month low of $32.35 and a twelve month high of $55.20. The company has a current ratio of 2.58, a quick ratio of 1.37 and a debt-to-equity ratio of 1.95.

In related news, CFO Gary J. Haire sold 731 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $32,814.59. Following the transaction, the chief financial officer now directly owns 1,911 shares in the company, valued at $85,784.79. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Joseph W. Dziedzic sold 3,182 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The stock was sold at an average price of $44.89, for a total transaction of $142,839.98. Following the transaction, the chief executive officer now owns 21,351 shares in the company, valued at $958,446.39. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 92,999 shares of company stock worth $4,326,494. 4.80% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the stock. Gabelli Funds LLC boosted its holdings in Integer by 4.5% during the fourth quarter. Gabelli Funds LLC now owns 186,000 shares of the medical equipment provider’s stock worth $8,426,000 after purchasing an additional 8,000 shares during the last quarter. Algert Global LLC raised its position in Integer by 7.7% in the fourth quarter. Algert Global LLC now owns 54,533 shares of the medical equipment provider’s stock worth $2,470,000 after acquiring an additional 3,915 shares during the period. LSV Asset Management raised its position in Integer by 0.8% in the fourth quarter. LSV Asset Management now owns 1,689,257 shares of the medical equipment provider’s stock worth $76,523,000 after acquiring an additional 14,200 shares during the period. Hussman Strategic Advisors Inc. raised its position in Integer by 200.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 75,000 shares of the medical equipment provider’s stock worth $3,397,000 after acquiring an additional 50,000 shares during the period. Finally, Bessemer Group Inc. raised its position in Integer by 623.3% in the fourth quarter. Bessemer Group Inc. now owns 31,100 shares of the medical equipment provider’s stock worth $1,409,000 after acquiring an additional 26,800 shares during the period. Institutional investors and hedge funds own 95.43% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.com-unik.info/2018/02/05/integer-itgr-upgraded-at-valuengine.html.

About Integer

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit